Page last updated: 2024-08-23

alovudine and Acute Myelogenous Leukemia

alovudine has been researched along with Acute Myelogenous Leukemia in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	1 (33.33)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (33.33)	29.6817
2010's	1 (33.33)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Albertella, M; Barghout, SH; Gronda, M; Hurren, R; Jeyaraju, DV; Jitkova, Y; Liyanage, SU; MacLean, N; Rizoska, B; Schimmer, AD; Siriwardena, TP; Targett-Adams, P; Wang, X; Yehudai, D	1
Bommer, M; Buck, AK; Bunjes, D; Döhner, H; Glatting, G; Juweid, ME; Kull, T; Möller, P; Mottaghy, FM; Reske, SN; Schulz, M; Stilgenbauer, S	1
Blau, IW; Elstner, E; Ihle, R; Langen, P; von Janta-Lipinski, M; Waechter, M	1

Trials

1 trial(s) available for alovudine and Acute Myelogenous Leukemia

Article	Year
First demonstration of leukemia imaging with the proliferation marker 18F-fluorodeoxythymidine. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2008, Volume: 49, Issue:11 Topics: Adult; Aged; Bone Marrow; Case-Control Studies; Cell Proliferation; Dideoxynucleosides; Female; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Positron-Emission Tomography; Tissue Distribution; Young Adult	2008

Article

Year

First demonstration of leukemia imaging with the proliferation marker 18F-fluorodeoxythymidine.

Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2008, Volume: 49, Issue:11

Topics: Adult; Aged; Bone Marrow; Case-Control Studies; Cell Proliferation; Dideoxynucleosides; Female; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Positron-Emission Tomography; Tissue Distribution; Young Adult

2008

Other Studies

2 other study(ies) available for alovudine and Acute Myelogenous Leukemia

Article	Year
The thymidine dideoxynucleoside analog, alovudine, inhibits the mitochondrial DNA polymerase γ, impairs oxidative phosphorylation and promotes monocytic differentiation in acute myeloid leukemia. Haematologica, 2019, Volume: 104, Issue:5 Topics: Animals; Antiviral Agents; Apoptosis; Cell Differentiation; Cell Proliferation; Dideoxynucleosides; DNA Polymerase gamma; Humans; Leukemia, Myeloid, Acute; Male; Mice; Mice, Inbred NOD; Mice, SCID; Mitochondria; Monocytes; Oxidative Phosphorylation; Thymidine; Tumor Cells, Cultured; Xenograft Model Antitumor Assays	2019
Sensitivity of CFU-GM from normal human bone marrow and leukaemic clonogenic cells (CFU-L) from blood of patients with myelogenous leukaemia to 3'-deoxy-3'-fluorothymidine in comparison to 3'-azido-3'-deoxythymidine. Blut, 1989, Volume: 59, Issue:5 Topics: Adolescent; Adult; Aged; Bone Marrow; Bone Marrow Cells; Dideoxynucleosides; Granulocytes; Hematopoietic Stem Cells; Humans; Leukemia, Myeloid, Acute; Neoplastic Stem Cells; Zidovudine	1989

Article

Year

The thymidine dideoxynucleoside analog, alovudine, inhibits the mitochondrial DNA polymerase γ, impairs oxidative phosphorylation and promotes monocytic differentiation in acute myeloid leukemia.

Haematologica, 2019, Volume: 104, Issue:5

Topics: Animals; Antiviral Agents; Apoptosis; Cell Differentiation; Cell Proliferation; Dideoxynucleosides; DNA Polymerase gamma; Humans; Leukemia, Myeloid, Acute; Male; Mice; Mice, Inbred NOD; Mice, SCID; Mitochondria; Monocytes; Oxidative Phosphorylation; Thymidine; Tumor Cells, Cultured; Xenograft Model Antitumor Assays

2019

Sensitivity of CFU-GM from normal human bone marrow and leukaemic clonogenic cells (CFU-L) from blood of patients with myelogenous leukaemia to 3'-deoxy-3'-fluorothymidine in comparison to 3'-azido-3'-deoxythymidine.

Blut, 1989, Volume: 59, Issue:5

Topics: Adolescent; Adult; Aged; Bone Marrow; Bone Marrow Cells; Dideoxynucleosides; Granulocytes; Hematopoietic Stem Cells; Humans; Leukemia, Myeloid, Acute; Neoplastic Stem Cells; Zidovudine

1989